{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:05:10Z","timestamp":1787061910305,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020638","name":"Allergan Aesthetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.toxicon.2025.108372","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:08:28Z","timestamp":1745500108000},"page":"108372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Botulinum neurotoxin type DC (BoNT\/DC) cleavage of VAMP3 reduces melanin production in melanocytes"],"prefix":"10.1016","volume":"261","author":[{"given":"Shiazah","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond E.","family":"Boissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-9145","authenticated-orcid":false,"given":"Amy","family":"Brideau-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Sondergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2025.108372_bib1","first-page":"858","article-title":"Understanding the female African American facial aesthetic patient","volume":"18","author":"Alexis","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib2","first-page":"616","article-title":"Myths and knowledge gaps in the aesthetic treatment of patients with skin of color","volume":"18","author":"Alexis","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib3","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.str.2013.06.026","article-title":"Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II","volume":"21","author":"Berntsson","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.toxicon.2025.108372_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091438","article-title":"PMEL amyloid fibril formation: the bright steps of pigmentation","volume":"17","author":"Bissig","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxicon.2025.108372_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1600-0854.2006.00425.x","article-title":"The quest for the mechanism of melanin transfer","volume":"7","author":"Bossche","year":"2006","journal-title":"Traffic"},{"key":"10.1016\/j.toxicon.2025.108372_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14100708","article-title":"Botulinum neurotoxin type A directly affects sebocytes and modulates oleic acid-induced lipogenesis","volume":"14","author":"Brami-Cherrier","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108372_bib7","doi-asserted-by":"crossref","first-page":"244s","DOI":"10.1177\/1091581810385956","article-title":"Final report of the safety assessment of kojic acid as used in cosmetics","volume":"29","author":"Burnett","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.toxicon.2025.108372_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0006-291X(84)91282-8","article-title":"Gangliosides of normal and neoplastic human melanocytes","volume":"120","author":"Carubia","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxicon.2025.108372_bib9","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1111\/jocd.14746","article-title":"Hyperpigmentation: looking beyond hydroquinone","volume":"21","author":"Charoo","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib10","first-page":"633","article-title":"Understanding the female Asian American facial aesthetic patient","volume":"18","author":"Chiu","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib11","series-title":"Presented at the American Society for Dermatologic Surgery (ASDS) 2023 Annual Meeting, Chicago, IL, USA","article-title":"Aesthetic concerns regarding face and body appearance among Asian women: results from Asian female-identifying participants of a large survey of aesthetically-inclined adults in the US","author":"Chiu","year":"2023"},{"key":"10.1016\/j.toxicon.2025.108372_bib12","series-title":"Poster Presented at the American Society for Dermatologic Surgery (ASDS) 2023 Annual Meeting, Chicago, IL, USA","article-title":"Aesthetic concerns regarding face and body appearance among black women: results from a large, multigenerational survey of aesthetically-inclined adults in the US","author":"Downie","year":"2023"},{"key":"10.1016\/j.toxicon.2025.108372_bib13","first-page":"623","article-title":"Understanding the female Hispanic and Latino American facial aesthetic patient","volume":"18","author":"Fabi","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib14","article-title":"Lotus sprout extract induces selective melanosomal autophagy and reduces pigmentation","author":"Geyfman","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib15","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1039\/C6AN00693K","article-title":"Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry","volume":"141","author":"Hansbauer","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.toxicon.2025.108372_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.2910410303","article-title":"Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, Naevi, primary and metastatic melanoma","volume":"41","author":"Hersey","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.toxicon.2025.108372_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003369","article-title":"Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT\/A)","volume":"9","author":"Jacky","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2025.108372_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DSS.0000000000000876","article-title":"Facial treatment preferences among aesthetically oriented men","volume":"42","author":"Jagdeo","year":"2016","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2025.108372_bib19","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-021-87331-7","article-title":"Characterization of Clostridium botulinum neurotoxin serotype A (BoNT\/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay","volume":"11","author":"James","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2025.108372_bib20","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1111\/jocd.14966","article-title":"Study of botulinum toxin type A for the treatment of ultraviolet B-induced hyperpigmentation: a prospective, randomized, controlled trial","volume":"21","author":"Jurairattanaporn","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib21","doi-asserted-by":"crossref","first-page":"40806","DOI":"10.1074\/jbc.M112.404244","article-title":"Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry","volume":"287","author":"Karalewitz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2025.108372_bib22","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1242\/jcs.052761","article-title":"VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion","volume":"122","author":"Kean","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.toxicon.2025.108372_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/DSS.0000000000002494","article-title":"A randomized, double-blinded study evaluating the safety and efficacy of AbobotulinumtoxinA injections for oily skin of the forehead: a dose-response analysis","volume":"47","author":"Kesty","year":"2021","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2025.108372_bib24","article-title":"Botulinum neurotoxin type A induces TLR2-mediated inflammatory responses in macrophages","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2025.108372_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2021.12.065","article-title":"Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation","volume":"88","author":"Ko","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/icb\/icab078","article-title":"Melanosome biogenesis in the pigmentation of mammalian skin","volume":"61","author":"Le","year":"2021","journal-title":"Integr. Comp. Biol."},{"key":"10.1016\/j.toxicon.2025.108372_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/jocd.15984","article-title":"Potential role of the cell-penetrating peptide-conjugated soluble N-ethylmaleimide-Sensitive factor attachment protein receptor motif of vesicle-associated membrane protein 2-patterned peptide in novel cosmeceutical skin product development","volume":"23","author":"Lee","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib28","article-title":"Clostridium botulinum type C, D, C\/D, and D\/C: an update","volume":"13","author":"Meurens","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108372_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","article-title":"Sebum production alteration after botulinum toxin type A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation","volume":"35","author":"Min","year":"2015","journal-title":"Aesthetic Surg. J."},{"key":"10.1016\/j.toxicon.2025.108372_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094466","article-title":"Melanin transfer in the epidermis: the pursuit of skin pigmentation control mechanisms","volume":"22","author":"Moreiras","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxicon.2025.108372_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-695X.2010.00774.x","article-title":"Studies on botulinum neurotoxins type\/C1 and mosaic\/DC using endopep-MS and proteomics","volume":"61","author":"Moura","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108372_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vetmic.2009.07.023","article-title":"Characterization of the D\/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan","volume":"140","author":"Nakamura","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108372_bib33","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/IAI.00302-12","article-title":"Unique biological activity of botulinum D\/C mosaic neurotoxin in murine species","volume":"80","author":"Nakamura","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2025.108372_bib34","first-page":"86","article-title":"Antibodies against GM1 gangliosides associated with metastatic melanoma","volume":"21","author":"Nicolae","year":"2013","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.toxicon.2025.108372_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2011.06.173","article-title":"Structural and mutational analyses of the receptor binding domain of botulinum D\/C mosaic neurotoxin: insight into the ganglioside binding mechanism","volume":"411","author":"Nuemket","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxicon.2025.108372_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1524-4725.2012.02504.x","article-title":"The potential effect of botulinum toxin type A on human dermal fibroblasts: an in vitro study","volume":"38","author":"Oh","year":"2012","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2025.108372_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2015.04.015","article-title":"Activity of botulinum neurotoxin type D (strain 1873) in human neurons","volume":"101","author":"Pellett","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108372_bib38","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/1873-3468.13508","article-title":"Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations","volume":"593","author":"Pellett","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2025.108372_bib39","first-page":"3233","article-title":"Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins","volume":"125","author":"Peng","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.toxicon.2025.108372_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004177","article-title":"Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins","volume":"10","author":"Peng","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2025.108372_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphotobiol.2014.03.009","article-title":"Anti-photoaging potential of botulinum toxin type A in UVB-induced premature senescence of human dermal fibroblasts in vitro through decreasing senescence-related proteins","volume":"133","author":"Permatasari","year":"2014","journal-title":"J. Photochem. Photobiol., B"},{"key":"10.1016\/j.toxicon.2025.108372_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dsu.12097","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin","volume":"39","author":"Rose","year":"2013","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2025.108372_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12050276","article-title":"Analysis of motor neurons differentiated from human induced pluripotent stem cells for the use in cell-based botulinum neurotoxin activity assays","volume":"12","author":"Schenke","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108372_bib44","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size","volume":"7","author":"Shah","year":"2008","journal-title":"J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.toxicon.2025.108372_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2958.2011.07682.x","article-title":"The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites","volume":"81","author":"Strotmeier","year":"2011","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.toxicon.2025.108372_bib46","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/DSS.0000000000002486","article-title":"A prospective, split-face, randomized study comparing picosecond to Q-switched Nd: YAG laser for treatment of epidermal and dermal pigmented lesions in Asians","volume":"46","author":"Ungaksornpairote","year":"2020","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2025.108372_bib47","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1097\/DSS.0000000000002943","article-title":"A study of botulinum toxin A for ultraviolet-induced hyperpigmentation: a randomized controlled trial","volume":"47","author":"Vachiramon","year":"2021","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2025.108372_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14060417","article-title":"Incobotulinum toxin type A for treatment of ultraviolet-B-induced hyperpigmentation: a prospective, randomized, controlled trial","volume":"14","author":"Vachiramon","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108372_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/1673-5374.343890","article-title":"Gangliosides in nervous system development, regeneration, and pathologies","volume":"18","author":"Vasques","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.toxicon.2025.108372_bib50","doi-asserted-by":"crossref","first-page":"19820","DOI":"10.1074\/jbc.M010838200","article-title":"Syntaxin 7 complexes with mouse Vps10p tail interactor 1b, syntaxin 6, vesicle-associated membrane protein (VAMP)8, and VAMP7 in B16 melanoma cells","volume":"276","author":"Wade","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2025.108372_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jaad.2022.01.051","article-title":"Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders","volume":"88","author":"Wang","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib52","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.toxicon.2025.108372_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1348-0421.2012.00434.x","article-title":"Specificity of botulinum protease for human VAMP family proteins","volume":"56","author":"Yamamoto","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2025.108372_bib54","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/jid.2013.156","article-title":"Syntaxin-3 is required for melanosomal localization of Tyrp1 in melanocytes","volume":"133","author":"Yatsu","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.toxicon.2025.108372_bib55","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41467-017-01534-z","article-title":"Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2025.108372_bib56","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/exd.14662","article-title":"Biological activities and safety data of kojic kcid and its derivatives: a review","volume":"31","author":"Zilles","year":"2022","journal-title":"Exp. Dermatol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:29:52Z","timestamp":1747945792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"alternative-id":["S0041010125001461"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108372","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum neurotoxin type DC (BoNT\/DC) cleavage of VAMP3 reduces melanin production in melanocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108372"}}